Skip to main navigation Skip to search Skip to main content

Indoline‐6‐Sulfonamide Inhibitors of the Bacterial Enzyme DapE

  • Cory T Reidl
  • , Tahirah K Heath
  • , Iman Darwish
  • , Rachel M Torrez
  • , Maxwell Moore
  • , Elliot Gild
  • , Boguslaw P Nocek
  • , Anna Starus
  • , Richard C Holz
  • , Daniel P Becker
  • Loyola University Chicago
  • Argonne National Laboratory
  • Colorado School of Mines
  • Midwest Center for Structural Genomics and Structural Biology Center

Research output: Contribution to journalArticlepeer-review

Abstract

Inhibitors of the bacterial enzyme dapE-encoded N-succinyl-l,l-diaminopimelic acid desuccinylase (DapE; EC 3.5.1.18) hold promise as antibiotics with a new mechanism of action. Herein we describe the discovery of a new series of indoline sulfonamide DapE inhibitors from a high-throughput screen and the synthesis of a series of analogs. Inhibitory potency was measured by a ninhydrin-based DapE assay recently developed by our group. Molecular docking experiments suggest active site binding with the sulfonamide acting as a zinc-binding group (ZBG).

Original languageAmerican English
JournalChemistry: Faculty Publications and Other Works
Volume9
Issue number9
DOIs
StatePublished - Sep 11 2020

Keywords

  • diaminopimelate desuccinylase
  • DapE
  • ninhydrin enzyme assay
  • indoline
  • sulfonamide
  • enzyme inhibition
  • antibiotic

Disciplines

  • Biochemistry
  • Chemistry

Cite this